R1	Has_value Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
*	OR T10 T11 T12
R3	Subsumes Arg1:T9 Arg2:T10	
R4	AND Arg1:T8 Arg2:T9	
R5	Has_context Arg1:T5 Arg2:T8	
R6	Has_temporal Arg1:T9 Arg2:T15	
R7	Has_temporal Arg1:T16 Arg2:T17	
R8	Has_qualifier Arg1:T22 Arg2:T23	
*	OR T23 T24
R9	Has_qualifier Arg1:T25 Arg2:T26	
R10	AND Arg1:T25 Arg2:T22	
*	OR T28 T27
R11	AND Arg1:T31 Arg2:T32	
R13	Has_temporal Arg1:T31 Arg2:T30	
R12	AND Arg1:T28 Arg2:T31	
*	OR T36 T37
R16	AND Arg1:T36 Arg2:T35	
R17	AND Arg1:T39 Arg2:T40	
*	OR T36 T39
R14	Has_temporal Arg1:T35 Arg2:T34	
R15	Has_temporal Arg1:T40 Arg2:T34	
R18	Has_context Arg1:T36 Arg2:T29	
*	OR T43 T44
R19	Has_context Arg1:T43 Arg2:T42	
R20	Has_context Arg1:T43 Arg2:T42	
R21	Has_context Arg1:T44 Arg2:T42	
R22	AND Arg1:T43 Arg2:T46	
R23	AND Arg1:T48 Arg2:T47	
R24	Has_qualifier Arg1:T50 Arg2:T51	
*	OR T49 T53 T52
R26	AND Arg1:T50 Arg2:T49	
R27	Has_temporal Arg1:T60 Arg2:T59	
R28	AND Arg1:T58 Arg2:T60	
R29	Has_context Arg1:T60 Arg2:T61	
R30	Has_qualifier Arg1:T65 Arg2:T66	
R31	Has_value Arg1:T67 Arg2:T68	
R32	AND Arg1:T69 Arg2:T67	
R33	Has_qualifier Arg1:T69 Arg2:T72	
R34	Has_negation Arg1:T72 Arg2:T73	
*	OR T74 T75
R35	AND Arg1:T72 Arg2:T74	
R36	AND Arg1:T77 Arg2:T79	
R37	Has_temporal Arg1:T79 Arg2:T78	
R38	Has_context Arg1:T79 Arg2:T80	
R39	AND Arg1:T79 Arg2:T69	
R40	Has_qualifier Arg1:T81 Arg2:T82	
R41	Has_value Arg1:T83 Arg2:T84	
*	OR T87 T86
R44	Has_negation Arg1:T91 Arg2:T92	
R45	AND Arg1:T95 Arg2:T96	
R46	Has_temporal Arg1:T96 Arg2:T97	
*	OR T93 T94
*	OR T98 T70
R47	Has_qualifier Arg1:T69 Arg2:T98	
R42	Has_qualifier Arg1:T85 Arg2:T87	
R43	AND Arg1:T85 Arg2:T83	
R48	Has_qualifier Arg1:T85 Arg2:T91	
R49	AND Arg1:T91 Arg2:T93	
R50	AND Arg1:T96 Arg2:T85	
*	OR T54 T102
R25	Has_qualifier Arg1:T55 Arg2:T54	
R51	Has_negation Arg1:T55 Arg2:T101	
R52	AND Arg1:T49 Arg2:T55	
*	OR T63 T64
R53	AND Arg1:T60 Arg2:T62	
R54	Has_temporal Arg1:T9 Arg2:T14	
R55	Has_index Arg1:T15 Arg2:T105	
R56	Has_index Arg1:T14 Arg2:T106	
R57	Has_index Arg1:T17 Arg2:T107	
*	OR T108 T110 T109
R58	Has_qualifier Arg1:T3 Arg2:T108	
R59	Has_value Arg1:T112 Arg2:T113	
R60	Has_context Arg1:T6 Arg2:T8	
R61	AND Arg1:T85 Arg2:T89	
R62	AND Arg1:T89 Arg2:T90	
R63	AND Arg1:T89 Arg2:T83	
R64	AND Arg1:T90 Arg2:T83	
R65	Has_qualifier Arg1:T89 Arg2:T91	
R66	Has_qualifier Arg1:T90 Arg2:T91	
R67	AND Arg1:T96 Arg2:T89	
R68	AND Arg1:T96 Arg2:T90	
R69	AND Arg1:T60 Arg2:T63	
T1	Measurement 30 54	Breast - Karnofsky score
T2	Value 55 59	> 50
T3	Measurement 97 147	Gynecologic Oncology Group (GOG) performance score
T4	Value 148 150	â‰¤2
T5	Person 155 161	female
T6	Condition 169 191	childbearing potential
T8	Observation 197 207	willing to
T9	Procedure 221 234	contraception
T10	Drug 236 244	hormonal
T11	Procedure 246 260	barrier method
T12	Procedure 262 272	abstinence
T14	Temporal 299 338	for the duration of study participation
T15	Temporal 274 294	prior to study entry
T16	Condition 341 362	Normal organ function
T17	Temporal 363 392	within 14 days of study entry
T18	Condition 443 467	Metastatic breast cancer
T19	Condition 474 499	Metastatic ovarian cancer
T20	Condition 506 535	Metastatic endometrial cancer
T21	Condition 542 568	Metastatic cervical cancer
T22	Condition 586 604	metastatic disease
T23	Qualifier 575 585	Measurable
T24	Value 606 610	>1cm
T25	Value 615 627	at least one
T26	Qualifier 628 653	site other than bone-only
T27	Observation 673 691	failure to respond
T28	Observation 655 669	Progression on
T30	Temporal 708 716	previous
T31	Procedure 717 737	chemotherapy regimen
T32	Condition 742 760	metastatic disease
T29	Observation 762 776	Progression on
T34	Temporal 777 782	prior
T35	Procedure 783 812	therapy with a hormonal agent
T36	Condition 816 833;859 867	estrogen receptor positive
T37	Condition 837 867	progesterone receptor positive
T39	Condition 896 913	HER2-neu positive
T40	Procedure 783 795;881 892	therapy with trastuzumab
T42	Observation 930 948	progressed through
T43	Procedure 949 956;972 979	hormone therapy
T44	Procedure 960 979	trastuzumab therapy
T46	Procedure 1009 1029	chemotherapy regimen
T47	Measurement 1076 1129	Response Evaluation Criteria in Solid Tumors (RECIST)
T48	Condition 1043 1061	metastatic disease
T49	Condition 1195 1220	epithelial ovarian cancer
T50	Procedure 1170 1184	histologically
T51	Qualifier 1131 1144	Primary tumor
T52	Condition 1222 1243	fallopian tube cancer
T53	Condition 1248 1273	primary peritoneal cancer
T54	Qualifier 1279 1289	borderline
T55	Condition 1317 1337	epithelial carcinoma
T58	Multiplier 1367 1379	at least two
T59	Temporal 1380 1388	previous
T60	Procedure 1389 1410	chemotherapy regimens
T61	Observation 1360 1366	failed
T62	Drug 1412 1422	Paclitaxel
T63	Drug 1478 1487	cisplatin
T64	Drug 1491 1502	carboplatin
T65	Condition 1567 1585	metastatic disease
T66	Qualifier 1556 1566	Measurable
T67	Measurement 1587 1601	Histologically
T68	Value 1602 1608	proven
T72	Qualifier 1664 1694	amenable to curative treatment
T73	Negation 1660 1663	not
T74	Procedure 1700 1707	surgery
T75	Procedure 1715 1732	radiation therapy
T77	Value 1748 1749	2
T78	Temporal 1750 1758	previous
T79	Procedure 1759 1777	treatment regimens
T80	Observation 1741 1747	failed
T81	Condition 1790 1808	metastatic disease
T82	Qualifier 1779 1789	Measurable
T83	Measurement 1810 1824	Histologically
T84	Value 1825 1831	proven
T85	Condition 1856 1879	squamous cell carcinoma
T86	Qualifier 1845 1855	persistent
T87	Qualifier 1832 1841	recurrent
T89	Condition 1881 1904	adenosquamous carcinoma
T90	Condition 1909 1937	adenocarcinoma of the cervix
T91	Qualifier 1950 1980	amenable to curative treatment
T92	Negation 1946 1949	not
T93	Procedure 1986 1993	surgery
T94	Procedure 2001 2018	radiation therapy
T95	Value 2034 2035	2
T96	Procedure 2045 2063	treatment regimens
T97	Temporal 2036 2044	previous
T69	Condition 1633 1651	endometrial cancer
T70	Qualifier 1622 1632	persistent
T98	Qualifier 1609 1618	recurrent
T101	Negation 1275 1278	not
T102	Qualifier 1293 1316	low malignant potential
T105	Reference_point 283 294	study entry
T106	Reference_point 319 338	study participation
T107	Reference_point 381 392	study entry
T108	Qualifier 62 69	Ovarian
T109	Qualifier 71 82	endometrial
T110	Qualifier 86 94	cervical
T112	Measurement 9 27	performance status
T113	Value 0 8	Adequate
T114	Non-representable 0 27	Adequate performance status
